Literature DB >> 17870089

Substrate modulation of enzyme activity in the herpesvirus protease family.

Ana Lazic1, David H Goetz, Anson M Nomura, Alan B Marnett, Charles S Craik.   

Abstract

The herpesvirus proteases are an example in which allosteric regulation of an enzyme activity is achieved through the formation of quaternary structure. Here, we report a 1.7 A resolution structure of Kaposi's sarcoma-associated herpesvirus protease in complex with a hexapeptide transition state analogue that stabilizes the dimeric state of the enzyme. Extended substrate binding sites are induced upon peptide binding. In particular, 104 A2 of surface are buried in the newly formed S4 pocket when tyrosine binds at this site. The peptide inhibitor also induces a rearrangement of residues that stabilizes the oxyanion hole and the dimer interface. Concomitant with the structural changes, an increase in catalytic efficiency of the enzyme results upon extended substrate binding. A nearly 20-fold increase in kcat/KM results upon extending the peptide substrate from a tetrapeptide to a hexapeptide exclusively due to a KM effect. This suggests that the mechanism by which herpesvirus proteases achieve their high specificity is by using extended substrates to modulate both the structure and activity of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17870089      PMCID: PMC2078331          DOI: 10.1016/j.jmb.2007.07.073

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  45 in total

1.  One functional switch mediates reversible and irreversible inactivation of a herpesvirus protease.

Authors:  Anson M Nomura; Alan B Marnett; Nobuhisa Shimba; Volker Dötsch; Charles S Craik
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

2.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

3.  The 25 amino acid residues at the carboxy terminus of the herpes simplex virus type 1 UL26.5 protein are required for the formation of the capsid shell around the scaffold.

Authors:  J Kennard; F J Rixon; I M McDougall; J D Tatman; V G Preston
Journal:  J Gen Virol       Date:  1995-07       Impact factor: 3.891

4.  The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth.

Authors:  M Gao; L Matusick-Kumar; W Hurlburt; S F DiTusa; W W Newcomb; J C Brown; P J McCann; I Deckman; R J Colonno
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Characterization of the Epstein-Barr virus proteinase and comparison with the human cytomegalovirus proteinase.

Authors:  G Donaghy; R Jupp
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

6.  Investigating the role of histidine 157 in the catalytic activity of human cytomegalovirus protease.

Authors:  R Khayat; R Batra; M J Massariol; L Lagacé; L Tong
Journal:  Biochemistry       Date:  2001-05-29       Impact factor: 3.162

7.  Dimerization and activation of the herpes simplex virus type 1 protease.

Authors:  U Schmidt; P L Darke
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

8.  Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries.

Authors:  J L Harris; B J Backes; F Leonetti; S Mahrus; J A Ellman; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

9.  De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.

Authors:  Michael Lagunoff; Jill Bechtel; Eleni Venetsanakos; Anne-Marie Roy; Nancy Abbey; Brian Herndier; Martin McMahon; Don Ganem
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

10.  Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation.

Authors:  S R LaPlante; N Aubry; P R Bonneau; D R Cameron; L Lagacé; M J Massariol; H Montpetit; C Plouffe; S H Kawai; B D Fulton; Z Chen; F Ni
Journal:  Biochemistry       Date:  1998-07-07       Impact factor: 3.162

View more
  10 in total

1.  Enzyme inhibition by allosteric capture of an inactive conformation.

Authors:  Gregory M Lee; Tina Shahian; Aida Baharuddin; Jonathan E Gable; Charles S Craik
Journal:  J Mol Biol       Date:  2011-06-22       Impact factor: 5.469

Review 2.  Current and potential treatments for ubiquitous but neglected herpesvirus infections.

Authors:  Jonathan E Gable; Timothy M Acker; Charles S Craik
Journal:  Chem Rev       Date:  2014-10-02       Impact factor: 60.622

3.  Inhibition of a viral enzyme by a small-molecule dimer disruptor.

Authors:  Tina Shahian; Gregory M Lee; Ana Lazic; Leggy A Arnold; Priya Velusamy; Christina M Roels; R Kiplin Guy; Charles S Craik
Journal:  Nat Chem Biol       Date:  2009-07-26       Impact factor: 15.040

4.  A screening strategy for trapping the inactive conformer of a dimeric enzyme with a small molecule inhibitor.

Authors:  Charles S Craik; Tina Shahian
Journal:  Methods Mol Biol       Date:  2012

5.  Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease.

Authors:  Jonathan E Gable; Gregory M Lee; Timothy M Acker; Kaitlin R Hulce; Eric R Gonzalez; Patrick Schweigler; Samu Melkko; Christopher J Farady; Charles S Craik
Journal:  ChemMedChem       Date:  2016-01-28       Impact factor: 3.466

6.  Dimerization-Induced Allosteric Changes of the Oxyanion-Hole Loop Activate the Pseudorabies Virus Assemblin pUL26N, a Herpesvirus Serine Protease.

Authors:  Martin Zühlsdorf; Sebastiaan Werten; Barbara G Klupp; Gottfried J Palm; Thomas C Mettenleiter; Winfried Hinrichs
Journal:  PLoS Pathog       Date:  2015-07-10       Impact factor: 6.823

7.  (±)-Japonones A and B, two pairs of new enantiomers with anti-KSHV activities from Hypericum japonicum.

Authors:  Linzhen Hu; Hucheng Zhu; Lei Li; Jinfeng Huang; Weiguang Sun; Junjun Liu; Hua Li; Zengwei Luo; Jianping Wang; Yongbo Xue; Yu Zhang; Yonghui Zhang
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

8.  The effect of dimerization and ligand binding on the dynamics of Kaposi's sarcoma-associated herpesvirus protease.

Authors:  David Bern; Dror Tobi
Journal:  Proteins       Date:  2022-02-05

9.  Evaluation of A-azepano-triterpenoids and related derivatives as antimicrobial and antiviral agents.

Authors:  Oxana Kazakova; Elena Tret'yakova; Dmitry Baev
Journal:  J Antibiot (Tokyo)       Date:  2021-07-12       Impact factor: 2.649

10.  Broad-spectrum allosteric inhibition of herpesvirus proteases.

Authors:  Jonathan E Gable; Gregory M Lee; Priyadarshini Jaishankar; Brian R Hearn; Christopher A Waddling; Adam R Renslo; Charles S Craik
Journal:  Biochemistry       Date:  2014-07-11       Impact factor: 3.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.